208 related articles for article (PubMed ID: 30468801)
21. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
[TBL] [Abstract][Full Text] [Related]
23. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
Ordóñez NG
Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
[TBL] [Abstract][Full Text] [Related]
24. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
25. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.
Choi JH; Ro JY
Semin Diagn Pathol; 2022 Mar; 39(2):120-130. PubMed ID: 34167847
[TBL] [Abstract][Full Text] [Related]
26. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging of neuroblastoma, ganglioneuroblastoma, and ganglioneuroma.
Wang YM; Li YW; Sheih CP; Hsu JC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(6):420-4. PubMed ID: 8592928
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors.
Kimura N; Pilichowska M; Date F; Kimura I; Schindler M
Clin Cancer Res; 1999 Nov; 5(11):3483-7. PubMed ID: 10589762
[TBL] [Abstract][Full Text] [Related]
29. The Case of an Asymptomatic Pheochromocytoma Masquerading as a Pancreatic Neuroendocrine Tumor.
Baumrucker C; Kalavar M; Barkin JA; Franceschi D
Pancreas; 2020 Aug; 49(7):e65-e66. PubMed ID: 32675787
[No Abstract] [Full Text] [Related]
30. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma.
Arihara Z; Takahashi K; Murakami O; Totsune K; Sone M; Satoh F; Ito S; Hayashi Y; Sasano H; Mouri T
Peptides; 2000 Apr; 21(4):565-70. PubMed ID: 10822113
[TBL] [Abstract][Full Text] [Related]
31. Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells.
Hoshi N; Sugino T; Suzuki T
Med Mol Morphol; 2009 Jun; 42(2):110-7. PubMed ID: 19536618
[TBL] [Abstract][Full Text] [Related]
32. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic utility of tyrosine hydroxylase in peripheral neuroblastic tumors].
Zhang N; Liu N; He LJ
Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):471-475. PubMed ID: 28728220
[No Abstract] [Full Text] [Related]
34. Diagnosis of neuroblastoma and ganglioneuroma using Raman spectroscopy.
Rabah R; Weber R; Serhatkulu GK; Cao A; Dai H; Pandya A; Naik R; Auner G; Poulik J; Klein M
J Pediatr Surg; 2008 Jan; 43(1):171-6. PubMed ID: 18206477
[TBL] [Abstract][Full Text] [Related]
35. Diffusion weighted imaging in differentiating malignant and benign neuroblastic tumors.
Serin HI; Gorkem SB; Doganay S; Cıracı S; Unal E; Guzel M; Kucuk A; Kurtsoy A; Coskun A
Jpn J Radiol; 2016 Sep; 34(9):620-4. PubMed ID: 27418194
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
[TBL] [Abstract][Full Text] [Related]
37. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
[TBL] [Abstract][Full Text] [Related]
38. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of tumors of the adrenal medulla.
Ilias I; Pacak K
Horm Metab Res; 2005 Dec; 37(12):717-21. PubMed ID: 16372223
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
